Evolent Health, Inc. (NYSE:EVH) Q1 2023 Results Conference Call May 3, 2023 5:00 PM ET

Company Participants

Seth Frank - VP, IR

Seth Blackley - CEO

John Johnson - CFO

Conference Call Participants

Sandy Draper - Guggenheim Partners

Anne Samuel - JP Morgan

Charles Rhyee - TD Cowen

David Larsen - BTIG

Jailendra Singh - Truist

Jeff Garro - Stephens

Jessica Tassan - Piper Sandler

Richard Close - Canaccord Genuity

Ryan Daniels - William Blair

Sean Dodge - RBC Capital Markets

Operator

Welcome to Evolent Health's Earnings Conference Call for the Quarter Ended March 31, 2023. As a reminder, this conference call is being recorded. Your host for the call today from Evolent Health are Seth Blackley, Chief Executive Officer; and John Johnson, Chief Financial Officer. This call will be archived and available later this evening for the next week via the webcast on the company's website in the section entitled Investor Relations.

I'll now hand the call over to Seth Frank, Evolent's Vice President of Investor Relations.

Seth Frank

Thank you, and good evening. This conference call will contain forward-looking statements under the U.S. federal laws. These statements are subject to risks and uncertainties that could cause actual results to differ materially from historical experience or present expectations.

A description of some of the risks and uncertainties can be found in the company's reports that are filed with the Securities and Exchange Commission, including cautionary statements included in our current and periodic filings. For additional information on the company's results and outlook, please refer to our first quarter press release issued earlier today.

Finally, as a reminder, reconciliations of non-GAAP measures discussed during today's call to the most direct comparable GAAP measures are available in the summary presentation available in the Investor Relations section of our website or in the company's press release issued today and posted on the Investor Relations section of the company's website, ir.evolenthealth.com, and the Form 8-K filed by the company with the SEC earlier today.

During management's presentation and discussion, we will reference certain GAAP and non-GAAP figures and metrics that can be found in our earnings release as well as a summary presentation available on the Events section of Evolent's IR website.

And now I will turn the call over to Evolent's CEO, Seth Blackley.

Seth Blackley

Good evening, and thanks for joining us. My prepared comments today will focus on updating you on our quarterly results, progress on our 3 operating priorities and the status of integrating our recent acquisitions. As you know, we're hosting an investor meeting in Arlington, Virginia with a live webcast option as well on May 23, and I'll preview that event at the end of this call. John will discuss the quarterly results in more detail. and our update on guidance for the year, and we'll look forward to taking your questions at the end as always.